• share
• favorite_border

Racial and ethnic disparities in systemic lupus erythematosus, and one of its worst complications, kidney failure, continue to grow in the U.S. The number of new cases of kidney failure due to lupus occurring among African Americans has now surpassed that in Caucasians, with a high proportion occurring among African American women, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

After forty years of decline, rheumatoid arthritis may be on the rise in women, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Tai chi is effective in the treatment of pain and physical impairment in people with severe knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Patients taking glucocorticoids (e.g., prednisone) sometimes suffer from a common side effect of the treatment: osteoporosis. Now, though, these patients may have a new option to prevent bone loss and fractures, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Denosumab can increase bone mass in post menopausal women, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Patients who have not had successful treatment for their gout may find new hope in pegloticase, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Etanercept and methotrexate are shown to be safe and effective for long-term, continuous treatment of juvenile arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Therapies commonly used to treat rheumatoid arthritis do not seem to cause cancer, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Genes might explain why some patients with rheumatoid arthritis respond better to anti-TNF therapy than others, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

A class of drugs known as syk kinase inhibitors appear to be effective in treating people with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Anakinra may be effective in the treatment of an estimated 30,000 children with a certain form of juvenile arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Children with juvenile rheumatoid arthritis may miss fewer days of school when treated with abatacept, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

The use of an antimalarial medication may prevent the development of diabetes in patients with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

When used in addition to other treatments, tadalafil is effective and well tolerated in the treatment of secondary Raynaud's phenomenon, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Both direct health care costs and costs associated with decreased work productivity are substantial for people with systemic lupus erythematosus, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Becoming pregnant when your lupus is clinically stable may be the key to fewer flares and a safer pregnancy, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

The first study comparing two therapies, mycophenolate mofetil and intravenous cyclophosphamide, for the treatment of lupus nephritis in adolescents, shows that both appear safe and effective according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Early and aggressive treatment with a combination of an anti-TNF therapy and a disease modifying antirheumatic drug could put rheumatoid arthritis into remission, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Initial treatment with a combination of disease-modifying anti-rheumatic drugs may be effective in slowing the progression of rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

People with rheumatoid arthritis may be at increased risk for periodontal disease, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

A common, low-risk treatment, may prevent kidney damage in patients with lupus, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

A clinical trial of a novel drug known as tanezumab has shown that treatment once every eight weeks significantly reduces pain in patients with knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Ayurvedic drugs may be safer, and just as effective, as glucosamine and celecoxib in treating patients with knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

A person's risk of heart attack nearly doubles within the first ten years after being diagnosed with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

Being overweight, particularly if you have a higher than average body mass index, may increase your risk for developing severe osteoarthritis in your hips and knees, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Francisco, Calif.

• share
• favorite_border

The American College of Rheumatology Research and Ed. Found. (ACR REF) has selected 15 experienced researchers from leading institutions to receive an estimated $6 million from the Foundation's Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign. The awards are the second round of grants funded by the $30 million national multi-year fundraising effort focused specifically on rheumatoid arthritis.

• share
• favorite_border

If Congress fails to permanently fix the flawed Sustainable Growth Rate, rheumatologists may be forced to close their doors to Medicare patients.

• share
• favorite_border

The American College of Rheumatology Research and Education Foundation (REF) today announced that it has successfully raised more than $18 million for innovative rheumatoid arthritis research.

• share
• favorite_border

Work factors, such as working few hours and being self-employed, continue to be the most important predictors of work disability and loss among patients with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Total joint replacement may reduce pain and disability in senior citizens with arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Among total knee replacement candidates, the likelihood of reporting lack of social support is higher among black patients compared to white patients, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Patients with arthritis may change work hours, the type and nature of their work or may lose their jobs due to disability related to their arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

When considering long-term benefits, surgery may be a better treatment option than local injections of corticosteroids when treating carpal tunnel syndrome, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Low vitamin D levels may cause greater knee pain and difficulty walking in patients with knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

The shoes you wear may have significant effects on your osteoarthritis of the knee, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Omega-3 fish oils may benefit lupus activity as well as cardiovascular effects for patients with lupus, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Sending bone density results directly to patients increases the likelihood that they will seek treatment and is a preferred method of physicians for communicating results, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Monitoring treatment and increasing adherence (willingness to follow prescribed treatment routine) may reduce fractures in patients with osteoporosis, according to research presented at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

A single injection of intra-articular botulinum toxin Type A may significantly decrease pain and improve shoulder function in osteoarthritis sufferers, according to researches presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Changing the way in which rheumatoid arthritis is diagnosed by including one new assessment and excluding two current assessments may allow for the identification and inclusion of a larger number of patients with early disease in clinical studies, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.

• share
• favorite_border

Total knee replacement is cost effective for the treatment of end-stage arthritis, even when treating high-risk patients, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Testing patients for anti-cyclic citrullinated antibodies, also known as anti-CCP antibodies, before they are seen by a rheumatologist, could result in a diagnosis and a shorter delay before definitive treatment is begun, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.

• share
• favorite_border

Anakinra (Kineret), a medication used in the treatment of rheumatoid arthritis in adults, improves physical function in children and young adults with neonatal-onset multisystem inflammatory disease, and may provide a clue about what causes these types of diseases, according to research presented this week at the American College of Rheumatology's Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Rilonacept (IL-1 Trap) may substantially decrease both disease activity and pain in patients with chronic active gout, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

New potential risk factors for cardiac complications following total joint replacement have been identified, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Abatacept, a biologic therapy used to treat adults with moderate to severe rheumatoid arthritis, may be a well-tolerated treatment for juvenile arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Patients with juvenile rheumatoid arthritis experience marked improvements in their disease and less frequent flare-ups when being treated with adalimumab (Humira), according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Etanercept is safe in the long-term treatment of juvenile rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

An increasing number of elderly users of non-steroidal anti-inflammatory drugs may be at greater risk of serious gastrointestinal complications, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.

• share
• favorite_border

Having rheumatoid arthritis may increase your risk of stroke, according to research presented at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass.